Houx PJ, Vreeling FW, Jolles J. Rigorous health screening reduces age effect on memory scanning task. Brain Cognit 1991; 15: 246–260.
Houx PJ, Jolles J. Age-related decline of psychomotor speed: effects of age, brain health, sex, and education. Percept Motor Skills 1993; 76: 195–211.
Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. Lancet 1998; 351: 857–861.
Abildstrom H, Rasmussen LS, Rentowl P, et al. Cognitive dysfunction 1–2 after non-cardiac surgery in the elderly. Acta Anaesth Scand 2000; 44: 1246–1251.
Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. New Engl J Med 2001; 344: 395–402.
Robson MJ, Alston RP, Deary IJ, Andrews RP, Souter MJ, Yates S. Cognition after coronary artery surgery is not related to postoperative jugular bulb oxyhemoglobin desaturation. Anesth Analg 2000; 91: 1317–1326.
O'Brien JT. The ‘glucocorticoid cascade’ hypothesis in man – prolonged stress may cause permanent brain damage. Br J Psych 1997; 170: 199–201.
Lupien SJ, de Leon M, de Santi S, et al. Cortisol concentrations during human ageing predict hippocampal atrophy and memory deficits. Nat Neurosci 1998; 1: 69–73.
Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467–1472.
Tiraboschi P, Hansen LA, Alford M, et al. Cholinergic dysfunction in diseases with Lewy bodies. Neurology 2000; 54: 407–411.
Levy ML, Cummings JL, Kahn-Rose R. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease. Gerontology 1999; 45 (Suppl 1): 15–22.
Ebert U, Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 1998; 28: 944–949.
Blokland A, Honig W, Jolles J. Long-term consequences of repeated anaesthesia on reaction time performance in ageing rats. Br J Anaesth 2001; 87: 781–783.
Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 2001; 49: 200–210.
Perry EK, Lee MLW, Martin-Ruiz CM, et al. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psych 2001; 158: 1058–1066.
Court YA, Perry EK, Griffiths M, et al. Cholinergic nicotinic and muscarinic receptor binding in the developing and ageing human hippocampus. Brain Res Dev Brain Res 1997; 101: 93–105.
Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci 1977; 34: 247–265.
Tonner PH, Miller KW. Molecular sites of general anaesthetic action on acetylcholine receptors. Eur J Anaesthesiol 1995; 12: 21–30.
Dilger JP, Boguslavsky R, Barann M, Katz T, Vidal AM. Mechanisms of barbiturate inhibition of acetylcholine receptor channels. J Gen Physiol 1997; 109: 401–414.
Watanabe I, Andoh T, Furuya R, Sasaki T, Kamiya Y, Itoh H. Depressant and convulsant barbiturates both inhibit neuronal nicotinic acetylcholine receptors. Anesth Analg 1999; 88: 1406–1411.
Downie DL, Franks NP, Lieb WR. Effects of thiopental and its optical isomers on nicotinic acetylcholine receptors. Anesthesiology 2000; 93: 774–783.